Elaxim 50mg Injection
By Elaxim
Rx
1 Injection in a Vial

Composition
Tenecteplase(50mg)

Manufacturer - Gennova Biopharmaceuticals Ltd
EMCURE HOUSE T-184MIDC BHOSARI PUNE MH 411026 IN

Expires on or after
July, 2026

liver
Limited information is currently available regarding the use of Elaxim 50mg Injection in patients with liver disease. It is important to consult with your doctor for proper guidance before using this medication, especially if you have any liver-related issues. Your doctor will be able to assess your individual situation and determine the safety and efficacy of Elaxim 50mg Injection in relation to your liver health.

kidney
There is limited information on using Elaxim 50mg Injection in patients with kidney disease. Please consult your doctor.

alcohol
Consult your doctor when consuming alcohol with Elaxim 50mg Injection.

driving
It is better to consult your doctor. Refrain from driving if you have symptoms impairing focus and reaction time when using Elaxim 50mg Injection.

pregnancy
Elaxim 50mg Injection may not be safe to use during pregnancy. Animal studies have shown potential harm to the developing baby. Please consult your doctor for a thorough evaluation of the benefits and risks before using this medication.

breastfeeding
Elaxim 50mg Injection requires caution during breastfeeding. It is advisable to pause breastfeeding until the mother's treatment is finished and the drug is no longer in her system.
| Habit Forming | No |
| Chemical Class | Carboxylic Acid Derivative |
| Therapeutic Class | - |
| Action Class | Plasminogen Activators- Thrombolytics |
₹39500
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025
